The store will not work correctly when cookies are disabled.
7-(4'-carbamimidoylbiphenyl-3-yl)-2-naphthimidamide
ID: ALA4851966
PubChem CID: 164611720
Max Phase: Preclinical
Molecular Formula: C24H20N4
Molecular Weight: 364.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)c1ccc(-c2cccc(-c3ccc4ccc(C(=N)N)cc4c3)c2)cc1
Standard InChI: InChI=1S/C24H20N4/c25-23(26)17-8-4-15(5-9-17)18-2-1-3-19(12-18)20-10-6-16-7-11-21(24(27)28)14-22(16)13-20/h1-14H,(H3,25,26)(H3,27,28)
Standard InChI Key: GJZFKOOVWIMVFW-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
16.2512 -10.4005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2512 -11.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9702 -11.6403 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5364 -11.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5364 -12.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8216 -12.8803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1069 -12.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3921 -12.8803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3921 -13.7082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6730 -14.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9583 -13.7082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9583 -12.8803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2435 -12.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5286 -12.8803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8097 -12.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0949 -12.8803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3801 -12.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6652 -12.8803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9463 -12.4684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6652 -13.7082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3801 -11.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0949 -11.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8097 -11.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5286 -11.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2435 -11.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6730 -12.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1069 -11.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8216 -11.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
18 20 2 0
17 21 1 0
21 22 2 0
15 23 2 0
22 23 1 0
23 24 1 0
24 25 2 0
13 25 1 0
12 26 2 0
8 26 1 0
7 27 1 0
27 28 2 0
4 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.45 | Molecular Weight (Monoisotopic): 364.1688 | AlogP: 4.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 99.74 | Molecular Species: BASE | HBA: 2 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 11.69 | CX LogP: 4.10 | CX LogD: -0.71 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.31 | Np Likeness Score: -0.13 |
References
1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448] |